Issue: April 2020

Read more

April 20, 2020
1 min read
Save

MAVERICK-HCM

Issue: April 2020
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Assessment of safety and exploratory efficacy endpoints with once-daily mavacamten (MyoKardia) vs. placebo.

COBRA-BPS